ReviewCurrent atherosclerosis reports2025
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event.
Review in Current atherosclerosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Clinical Decision-Making and Imaging-Guided Follow-Up Strategies in Spontaneous Coronary Artery Dissection.Journal of cardiovascular development and disease · 2026Review
- Women's cardiovascular health in 2025:Saudi medical journal · 2026Review
- Acute Coronary Syndromes: State-of-the-Art Diagnosis, Management, and Secondary Prevention.Journal of clinical medicine · 2025Review
- Spontaneous Coronary Artery Dissection in Women.Reviews in cardiovascular medicine · 2025Article
- Unraveling Spontaneous Coronary Artery Dissection in Sudden Cardiac Death: Integrating Pathology, Genetics, and Molecular Autopsy.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purpose of reviewSpontaneous coronary artery dissection (SCAD) is an underrecognized cause of acute coronary syndrome, primarily affecting younger women without traditional risk factors. This review synthesizes current knowledge, identifies research gaps, and explores how precision medicine can improve diagnosis, treatment, and patient outcomes. RECENT
findingsSCAD is clinically and biologically heterogeneous, with variation in presentation, etiology, and recurrence risk. Contributing factors include sex-specific hormonal differences, vascular abnormalities, genetic predisposition, psychosocial stressors, and social determinants of health. Despite growing awareness, major gaps persist in risk stratification and tailored care. Emerging tools, including genomics, radiomics, and multiomics, offer opportunities to define SCAD subtypes and personalized management. A precision medicine framework integrating molecular, imaging, and social data may transform SCAD care. Continued research is essential to improve early detection, optimize therapy, and reduce recurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.